The price of the opioid overdose antidote naloxone has surged in recent years, potentially reducing availability of a critical lifesaving treatment, experts tell CBS MoneyWatch. They say a number of factors have led to the price increase.
A new study aims to reduce hepatitis C (HCV) transmission among young adults who inject drugs. The study will equip participants with strategies to avoid situations and practices that put them at risk of contracting HCV.
Hospitals are struggling to deal with an overwhelming number of patients with diseases that result from intravenous opioid use, including hepatitis C, endocarditis and the antibiotic-resistant infection MRSA.